A gene for Methyl-CpG binding protein 2 (MECP2), which locates Xq28, was recently found to be responsible for Rett syndrome. Although mutational analyses of MECP2 in Rett syndrome have been extensively analyzed, the mechanism(s) by which variable clinical phenotype occurred between affected monozygotic twins or sisters have not been clarified. We hypothesized that the difference of Xinactivation pattern might explain this phenomenon. With the method based on methylation-specific PCR, we analyzed polymorphic trinucleotide repeat in the human andorogen receptor gene mapped on Xq11.2-12, using DNA samples derived from previously described monozygotic twins and sisters together with their parents. Their clinical phenotypes were reported to be significantly different between siblings. We found that (1) maternally derived allele is predominantly active than paternally derived one in three out of four patients analyzed, (2) remaining one twin patient, whose ratio of active paternal allele is almost the same level as maternal allele, showed far much severe phenotype when compared with her counterpart. Together with the finding that most of the alleles with de novo mutation are from paternal X chromosome in sporadic cases, the existence of a mechanism that suppresses mutated paternal allele activation, resulting skewed X-inactivation to make clinical phenotype milder, might be speculated. Thus, when this mechanism fails to work sufficiently by an unknown reason, severer clinical phenotype could occur. q
Introduction
Recently, a gene encoding methyl-CpG binding protein 2 (MECP2) have been determined to be responsible for Rett syndrome (RTT), possibly an X-linked dominant male lethal disorder [1] . Since then, mutational analysis of the gene in RTT has been reported extensively. Cheadle et al.
[2] claimed the existence of a correlation of disease severity with mutation type and location. This correlation was supported by other reports. However, we have previously described female monozygotic twins [3] and sisters [4] with RTT, whose clinical phenotype are discrepant between siblings, indicating not only mutation but also some other factor(s) must modify clinical phenotypes. In fact, Amir et al. [5] claimed the importance of X chromosome inactivation on RTT phenotypes. We hypothesized that the difference of X-chromosome inactivation pattern could have some influence on severity. Here, we describe the data of mutational analysis of MECP2 of the patients, and thus, inactivation pattern analysis in all four patients and their parents. We found in the monozygotic twins, severity of symptoms seems to depend on the ratio of inactivation of paternally derived X chromosome; symptoms tended to be severe when ratio of active paternally derived X chromosome increased.
Materials and methods

Patients
Japanese monozygotic twins and sisters with RTT analyzed in this report were previously described (Fig. 1 ) [3, 4] . In the monozygotic twins, twin B is clinically severer than twin A as described in Ogawa et al. [3] . At present, they are 32 years old, the twin B became unable to walk since two years ago, on the other hand, the twin A can walk with other's support. In the sisters, clinical symptoms in the younger one is far severer than the elder one [4] ; the younger one has never walked and has seizures since 5 years old, on the other hand, the elder one has started walking since at age of 12 months and has no seizures. 
